All News

    The Power of Unity: Why the Lung Cancer Genetics Study Matters

    January 21st 2025, 10:00pm

    Article

    The Lung Cancer Genetics Study, a collaboration between lung cancer advocacy organizations, aims to explore the genetics of lung cancer

    Glucarpidase May Improve Renal Outcomes in Lymphoma, Leukemia

    January 21st 2025, 8:00pm

    Article

    Patients with lymphoma or leukemia with methotrexate-induced acute kidney injury experienced improved renal outcomes following glucarpidase treatment.

    My New Year’s Resolution After A Testicular Cancer Diagnosis

    January 21st 2025, 6:00pm

    Article

    My New Year's resolutions have evolved from seeking external goals to embracing personal growth and appreciating each day.

    Improving Efficacy, Minimizing Toxicity in Chemotherapy For Breast Cancer

    January 21st 2025, 4:00pm

    Video

    An expert spoke with CURE about providers’ “two-fold goal” when using chemotherapy to treat patients with breast cancer.

    Missed Chemotherapy Cycles Reduces Survival in Head and Neck Cancers

    January 21st 2025, 2:00pm

    Article

    Missing weekly cisplatin cycles was associated with worse OS in patients with head and neck cancers, particularly for those with p16-negative tumors.

    IMM-1-104 Treatment May Improve Responses in Pancreatic Cancer

    January 20th 2025, 10:00pm

    Article

    A phase 2a trial of IMM-1-104 plus chemotherapy demonstrated efficacy and tolerability in first- and second-line pancreatic cancer.

    Kate, Princess of Wales, ‘Got So Attached’ to Her Port During Cancer Treatment

    January 20th 2025, 8:00pm

    Video

    An expert spoke with CURE® about the emotional bonds that can develop while treating patients with cancer.

    Waiting for Results After My CLL Diagnosis

    January 20th 2025, 6:00pm

    Article

    Waiting for results of a CT scan after a cancer diagnosis is agonizing, as I anxiously await news on whether my disease has returned.

    Subcutaneous Dacogen Elicits Responses Among Some With Myelofibrosis

    January 20th 2025, 4:00pm

    Article

    Ten days of subcutaneous Dacogen resulted in responses among a third of patients with myelofibrosis.

    The Significance of the Subcutaneous Opdivo FDA Approval in Solid Tumors

    January 20th 2025, 2:00pm

    Article

    Dr. Balazs Halmos discusses the significance of the approval of subcutaneous Opdivo and what this treatment formulation means for those with solid tumors.